Campbell & Co Investment Adviser’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Sell |
38,752
-8,816
| -19% | -$261K | 0.07% | 450 |
|
|
2025
Q1 | $1.42M | Buy |
+47,568
| New | +$1.42M | 0.11% | 294 |
|
|
2024
Q3 | – | Sell |
-41,704
| Closed | -$1.34M | – | 1127 |
|
|
2024
Q2 | $1.34M | Buy |
+41,704
| New | +$1.34M | 0.11% | 262 |
|
|
2023
Q4 | – | Sell |
-12,871
| Closed | -$288K | – | 1130 |
|
|
2023
Q3 | $288K | Buy |
+12,871
| New | +$288K | 0.03% | 735 |
|
|
2023
Q2 | – | Sell |
-68,138
| Closed | -$1.63M | – | 921 |
|
|
2023
Q1 | $1.63M | Buy |
68,138
+57,544
| +543% | +$1.38M | 0.3% | 47 |
|
|
2022
Q4 | $246K | Sell |
10,594
-861
| -8% | -$20K | 0.06% | 618 |
|
|
2022
Q3 | $184K | Buy |
+11,455
| New | +$184K | 0.04% | 630 |
|
|
2022
Q2 | – | Sell |
-51,753
| Closed | -$1.05M | – | 709 |
|
|
2022
Q1 | $1.05M | Buy |
51,753
+41,753
| +418% | +$850K | 0.28% | 72 |
|
|
2021
Q4 | $187K | Buy |
+10,000
| New | +$187K | 0.06% | 544 |
|
|
2020
Q3 | – | Sell |
-11,855
| Closed | -$207K | – | 392 |
|
|
2020
Q2 | $207K | Buy |
+11,855
| New | +$207K | 0.26% | 212 |
|
|
2020
Q1 | – | Sell |
-11,875
| Closed | -$244K | – | 123 |
|
|
2019
Q4 | $244K | Buy |
11,875
+1,764
| +17% | +$36.2K | 0.07% | 503 |
|
|
2019
Q3 | $116K | Buy |
+10,111
| New | +$116K | 0.04% | 572 |
|